CCL2 and neoplasm: Despite this, it is clear that a reduction in plasma CCL2 associated with EPA treatment is linked to a marked difference in tumor biology evidenced by the differential gene expression between tumors from patients who did or did not exhibit a ‘CCL2 response’.